BDS-II

CAT: 0804-HY-P5818Size: 1 EachDry Ice: NoHazardous: No
CAT#: HY-P5818Size: 1 Each
Selected
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BDS-II is a peptide toxin, and is composed of 43 amino acids. BDS-II is a selective Kv3.4 channel inhibitor[1].
UNSPSC
12352209
Target
Sodium Channel
Type
Peptides
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bds-ii.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@@H](C)C(N1[C@@H](CCC1)C(N[C@@H](CSSC[C@@H]2NC3=O)C(N[C@@H](CC4=CC=CC=C4)C(N[C@@H](CSSC[C@@H](C(N[C@@H](CC5=CC=C(C=C5)O)C(N[C@@H](CCCCN)C(N[C@@H](CC6=CNC7=CC=CC=C67)C(N8[C@@H](CCC8)C(N[C@@H](CC(N)=O)C(N[C@H]3[C@@H](C)CC)=O)=O)=O)=O)=O)=O)NC9=O)C(N%10[C@@H](CCC%10)C(NCC(N[C@@H](CCCCN)C(N%11[C@@H](CCC%11)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCNC(N)=N)C(NCC(N[C@@H](CC(O)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CC%12=CNC%13=CC=CC=C%12%13)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(NCC(N[C@@H]([C@H](O)C)C(N[C@@H](CSSC[C@@H](C(N[C@@H](CC%14=CC=C(C=C%14)O)C(N%15[C@@H](CCC%15)C(N[C@@H](CC%16=CNC=N%16)C(O)=O)=O)=O)=O)NC2=O)C(N%17[C@@H](CCC%17)C(NCC(NCC(N[C@@H](CC%18=CC=C(C=C%18)O)C(NCC(N[C@@H](CC%19=CC=C(C=C%19)O)C(N[C@@H]([C@H](O)C)C(N[C@@H](CO)C(N[C@H]9CC(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C)N
Molecular Formula
C214H301N57O57S6
Molecular Weight
4776.42
References & Citations
[1]S Diochot, et al. Sea anemone peptides with a specific blocking activity against the fast inactivating potassium channel Kv3.4. J Biol Chem. 1998 Mar 20;273 (12) :6744-9.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported